Literature DB >> 3709932

Hepatic pyruvate metabolism during liver regeneration after partial hepatectomy in the rat.

P S Schofield, A L Kerbey, M C Sugden.   

Abstract

Hepatic pyruvate kinase (PK) and pyruvate dehydrogenase (PDHa) specific activities were decreased after partial hepatectomy or sham operation. The decreases were more marked and sustained after partial hepatectomy. These activity changes ensure that hepatic carbon flux after partial hepatectomy is predominantly in the direction of gluconeogenesis. The decrease in PK specific activity observed after partial hepatectomy was associated with a decreased PK activation ratio (activity measured at 0.15 mM PEP: activity measured at 5.0 mM PEP), and hepatic concentrations of PEP were increased. The low hepatic PDHa activity observed at the first day after partial hepatectomy occurred concomitantly with an increased fatty acid concentration. PDHa activity increased after inhibition of lipolysis. The results indicate that carbohydrate utilization is unimportant for hepatic energy supply during liver regeneration. There was no evidence that the control of PK or PDH in the regenerative liver after partial hepatectomy differed from that observed in the liver of the unoperated rat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709932     DOI: 10.1016/0020-711x(86)90188-6

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  3 in total

1.  Fructose 2,6-bisphosphate and 6-phosphofructo-2-kinase during liver regeneration.

Authors:  J L Rosa; F Ventura; J Carreras; R Bartrons
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

2.  Gene expression of regulatory enzymes of glycolysis/gluconeogenesis in regenerating rat liver.

Authors:  J L Rosa; R Bartrons; A Tauler
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

3.  Intravenous nicardipine does not alter hepatic blood flow after orthotopic liver transplant.

Authors:  M Raucoules-Aimé; M Drici; B Goubaux; Y Labib; C Ichai; J Gugenheim; D Grimaud
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.